Insiders · IBO

Mark Suseck

Chief Operating Officer at Impact Biomedical Inc. (IBO) since September 2024

Mark Suseck has filed 2 insider reports with the SEC since September 2024, as chief Operating Officer at Impact Biomedical Inc. (IBO). The latest filing, on November 5, 2026, reports grant or award at Impact Biomedical Inc. (IBO).

Filings
2
Companies
1
Bought on market
None
Sold on market
None

Companies where Mark Suseck is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Impact Biomedical Inc. logo
IBO
Impact Biomedical Inc.
Chief Operating Officersince September 202432,112$5.14Nov 5, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Mark Suseck with

Other insiders at the same companies

Questions about Mark Suseck

What is Mark Suseck's role at Impact Biomedical Inc.?
Mark Suseck reports to the SEC as chief Operating Officer at Impact Biomedical Inc. (IBO), according to the latest filing on November 5, 2026.
How many shares does Mark Suseck own?
After the latest filing that states it, Mark Suseck directly owned 32,112 shares of Impact Biomedical Inc. (IBO). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Mark Suseck bought or sold stock recently?
No open-market purchases or sales by Mark Suseck are on file. The filings report grant or award.
How do I get alerts when Mark Suseck files?
Follow Mark Suseck on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Mark Suseck filed 1 time in the last 90 days.

From SEC Forms 3, 4, 5 and 144 filed by Mark Suseck (SEC CIK 0002033773). Totals count each trade once, skipping amendments whose original is on file, from Sep 17, 2024 on. View on SEC EDGAR